CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,902 | $498.18 | $948K | 330,141 |
| 2026-09-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,018 | $498.77 | $508K | 329,123 |
| 2026-09-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,173 | $500.20 | $587K | 327,950 |
| 2026-09-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,221 | $501.17 | $612K | 326,729 |
| 2026-09-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,167 | $502.26 | $586K | 325,562 |
| 2026-09-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −701 | $503.33 | $353K | 324,861 |
| 2026-09-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −418 | $504.15 | $211K | 324,443 |
| 2026-09-08 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 480,410 | ||
| 2026-09-04 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-09-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $485.85 | $19K | 333,903 |
| 2026-09-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −223 | $486.88 | $109K | 333,680 |
| 2026-09-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,818 | $488.08 | $1.4M | 330,862 |
| 2026-09-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,425 | $489.12 | $1.7M | 327,437 |
| 2026-09-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,514 | $490.01 | $742K | 325,923 |
| 2026-09-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,160 | $490.94 | $569K | 324,763 |
| 2026-09-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −320 | $491.69 | $157K | 324,443 |
| 2026-09-04 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 489,910 | ||
| 2026-09-03 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +8,910 | $135.42 | $1.2M | 333,353 |
| 2026-09-03 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +590 | $117.76 | $69K | 333,943 |
| 2026-09-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $479.07 | $96K | 333,743 |
Page 40 of 121 · 2,404 trades